name: Sengers syndrome
category: Mendelian
parents: []
disease_term:
  preferred_term: Sengers syndrome
  term:
    id: MONDO:0008922
    label: Sengers syndrome
prevalence:
  - population: Reported cases
    percentage: Rare
    evidence:
      - reference: DOI:10.3389/fped.2021.639687
        supports: SUPPORT
        snippet: "Sengers syndrome (OMIM #212350) is a rare autosomal recessive disorder due to mutations in acylglycerol kinase (AGK) gene."
        explanation: This case report describes Sengers syndrome as a rare disorder.
epidemiology:
  - name: Limited number of reported long-term survivors
    description: >
      Published reports note that only a small number of cases have been followed
      into the second decade, highlighting the rarity of long-term survival data.
    notes: Evidence is based on case-report literature rather than population estimates.
    evidence:
      - reference: DOI:10.1186/s13052-022-01370-y
        supports: SUPPORT
        snippet: "Thus far few reported cases have survived the second decade at their latest examination, and no natural history data are available for the disease."
        explanation: This statement indicates the scarcity of long-term follow-up and limited reported cases.
inheritance:
  - name: Autosomal Recessive
    description: >
      Sengers syndrome is inherited in an autosomal recessive pattern, typically
      due to biallelic AGK variants (homozygous or compound heterozygous) with
      unaffected carrier parents.
    evidence:
      - reference: DOI:10.3389/fped.2021.639687
        supports: SUPPORT
        snippet: "Sengers syndrome (OMIM #212350) is a rare autosomal recessive disorder due to mutations in acylglycerol kinase (AGK) gene."
        explanation: This explicitly states autosomal recessive inheritance due to AGK variants.
      - reference: PMID:34164355
        supports: SUPPORT
        snippet: "Genetic testing of a boy revealed a homozygous pathogenic variant for Sengers syndrome in AGK (c.1131+2T>C) which was classified as likely pathogenic according to the ACMG guideline"
        explanation: Identification of a homozygous AGK variant supports autosomal recessive inheritance.
pathophysiology:
  - name: Loss of AGK disrupts TIM22 complex assembly in the mitochondrial inner membrane
    description: >
      Loss of functional AGK in Sengers syndrome perturbs TIM22 complex integrity
      at the mitochondrial inner membrane, initiating downstream defects in
      carrier protein import.
    cellular_components:
      - preferred_term: mitochondrial inner membrane
        term:
          id: GO:0005743
          label: mitochondrial inner membrane
    evidence:
      - reference: DOI:10.3390/ijms222413484
        supports: SUPPORT
        snippet: "AGK, a mitochondrial acylglycerol kinase, is not only involved in lipid signaling but is also a component of the TIM22 complex in the inner mitochondrial membrane, which mediates the import of a subset of membrane proteins."
        explanation: This establishes AGK as a TIM22 subunit in the mitochondrial inner membrane.
  - name: Impaired TIM22-mediated carrier import and one-carbon metabolism
    description: >
      TIM22 dysfunction in Sengers syndrome is associated with reduced import of
      inner-membrane carriers and sideroflexins, with downstream effects on
      mitochondrial one-carbon metabolism.
    biological_processes:
      - preferred_term: protein insertion into mitochondrial inner membrane
        term:
          id: GO:0045039
          label: protein insertion into mitochondrial inner membrane
      - preferred_term: one-carbon metabolic process
        term:
          id: GO:0006730
          label: one-carbon metabolic process
    evidence:
      - reference: DOI:10.1091/mbc.e20-06-0390
        supports: SUPPORT
        snippet: "Proteomic profiling of Sengers patient fibroblasts and AGK knockout models identifies remodeling of the mitochondrial proteome, including mitochondrial one-carbon metabolism enzymes, inner membrane serine transporters, sideroflexins, and Complex I subunits and assembly factors."
        explanation: This links AGK/TIM22 dysfunction to loss of carrier and sideroflexin import with effects on one-carbon metabolism.
  - name: Disrupted mitochondrial phospholipid metabolism
    description: >
      AGK loss alters phospholipid metabolism in mitochondrial membranes,
      contributing to disease pathogenesis.
    biological_processes:
      - preferred_term: phospholipid metabolic process
        term:
          id: GO:0006644
          label: phospholipid metabolic process
    evidence:
      - reference: DOI:10.3390/ijms222413484
        supports: SUPPORT
        snippet: "AGK mutations can alter both phospholipid metabolism and mitochondrial protein biogenesis, contributing to the pathogenesis of Sengers syndrome."
        explanation: This statement links AGK mutations to altered phospholipid metabolism in Sengers syndrome.
  - name: Oxidative phosphorylation deficiency
    description: >
      Impaired respiratory chain function with reduced complex I and V activity
      and decreased oxygen consumption in patient cells.
    biological_processes:
      - preferred_term: oxidative phosphorylation
        term:
          id: GO:0006119
          label: oxidative phosphorylation
    evidence:
      - reference: DOI:10.3390/ijms222413484
        supports: SUPPORT
        snippet: "Decreases in the oxygen consumption rate (OCR) and the OCR:ECAR (extracellular acidification rate) ratio in the patientâ€™s fibroblasts indicated reduced electron flow through the respiratory chain, and spectrophotometry revealed decreased activity of OXPHOS complexes I and V."
        explanation: This provides direct evidence of impaired oxidative phosphorylation and reduced complex I and V activity.
phenotypes:
  - name: Hypertrophic cardiomyopathy
    category: Cardiovascular
    phenotype_term:
      preferred_term: Hypertrophic cardiomyopathy
      term:
        id: HP:0001639
        label: Hypertrophic cardiomyopathy
    evidence:
      - reference: DOI:10.3389/fped.2021.639687
        supports: SUPPORT
        snippet: "Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation."
        explanation: This case report documents hypertrophic cardiomyopathy as a core feature of Sengers syndrome.
      - reference: DOI:10.1186/s13052-022-01370-y
        supports: SUPPORT
        snippet: "Sengers syndrome is characterized by congenital cataract, hypertrophic cardiomyopathy, mitochondrial myopathy, and lactic acidosis associated with mutations in AGK gene."
        explanation: This longitudinal case report reiterates hypertrophic cardiomyopathy as a defining feature.
  - name: Developmental cataract
    category: Ophthalmologic
    phenotype_term:
      preferred_term: Developmental cataract
      term:
        id: HP:0000519
        label: Developmental cataract
    evidence:
      - reference: DOI:10.3389/fped.2021.639687
        supports: SUPPORT
        snippet: "Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation."
        explanation: This identifies bilateral cataracts as a defining phenotype in Sengers syndrome.
      - reference: DOI:10.1186/s13052-022-01370-y
        supports: SUPPORT
        snippet: "Sengers syndrome is characterized by congenital cataract, hypertrophic cardiomyopathy, mitochondrial myopathy, and lactic acidosis associated with mutations in AGK gene."
        explanation: This report highlights congenital cataract as a core feature.
  - name: Myopathy
    category: Neuromuscular
    phenotype_term:
      preferred_term: Myopathy
      term:
        id: HP:0003198
        label: Myopathy
    evidence:
      - reference: DOI:10.3389/fped.2021.639687
        supports: SUPPORT
        snippet: "Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation."
        explanation: This case report includes myopathy among core Sengers syndrome features.
      - reference: DOI:10.1186/s13052-022-01370-y
        supports: SUPPORT
        snippet: "Sengers syndrome is characterized by congenital cataract, hypertrophic cardiomyopathy, mitochondrial myopathy, and lactic acidosis associated with mutations in AGK gene."
        explanation: This report specifies mitochondrial myopathy as a defining feature.
  - name: Lactic acidosis
    category: Metabolic
    phenotype_term:
      preferred_term: Lactic acidosis
      term:
        id: HP:0003128
        label: Lactic acidosis
    evidence:
      - reference: DOI:10.3389/fped.2021.639687
        supports: SUPPORT
        snippet: "Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation."
        explanation: This report documents lactic acidosis as a characteristic feature of Sengers syndrome.
      - reference: DOI:10.1186/s13052-022-01370-y
        supports: SUPPORT
        snippet: "Sengers syndrome is characterized by congenital cataract, hypertrophic cardiomyopathy, mitochondrial myopathy, and lactic acidosis associated with mutations in AGK gene."
        explanation: This longitudinal case report includes lactic acidosis as a defining feature.
  - name: Congestive heart failure
    category: Cardiovascular
    phenotype_term:
      preferred_term: Congestive heart failure
      term:
        id: HP:0001635
        label: Congestive heart failure
    evidence:
      - reference: DOI:10.3389/fped.2021.639687
        supports: SUPPORT
        snippet: "Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation."
        explanation: Heart failure is reported as the most severe clinical manifestation in these cases.
      - reference: PMID:34164355
        supports: SUPPORT
        snippet: "NT-proBNP reached 6,076 pg/ml (reference ranges <125 pg/ml) reflecting the state of the heart failure."
        explanation: This case report documents biochemical evidence of heart failure in a Sengers syndrome patient.
  - name: Aplasia of the ovary
    category: Genitourinary
    phenotype_term:
      preferred_term: Aplasia of the ovary
      term:
        id: HP:0010463
        label: Aplasia of the ovary
    evidence:
      - reference: DOI:10.1186/s13052-022-01370-y
        supports: SUPPORT
        snippet: "Here we provide a 20-year follow-up in two siblings with a benign form of Sengers syndrome, expanding the phenotypical spectrum of the disease by reporting a condition of ovarian agenesis."
        explanation: This report documents ovarian agenesis, consistent with ovarian aplasia.
genetic:
  - name: AGK
    association: Causative
    notes: Autosomal recessive
    evidence:
      - reference: DOI:10.3389/fped.2021.639687
        supports: SUPPORT
        snippet: "Sengers syndrome (OMIM #212350) is a rare autosomal recessive disorder due to mutations in acylglycerol kinase (AGK) gene."
        explanation: This statement identifies AGK mutations as the cause of Sengers syndrome with autosomal recessive inheritance.
      - reference: PMID:34164355
        supports: SUPPORT
        snippet: "After genetic analysis, a novel homozygous (c.1131+2T>C) variant of AGK gene was identified in the proband."
        explanation: This case report provides direct genetic evidence of a pathogenic AGK variant in Sengers syndrome.
environmental: []
biochemical:
  - name: Lactate
    presence: Elevated
    context: Lactic acidosis in Sengers syndrome
    biomarker_term:
      preferred_term: lactate
      term:
        id: CHEBI:24996
        label: lactate
    evidence:
      - reference: DOI:10.3389/fped.2021.639687
        supports: SUPPORT
        snippet: "Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation."
        explanation: This report documents lactic acidosis as a core biochemical abnormality.
      - reference: PMID:34164355
        supports: SUPPORT
        snippet: "However, the serum lactic acid increased significantly, reaching 14.99 mmol/L, so appropriate limitation of physical activities is recommended in daily life."
        explanation: This case report provides quantitative evidence of markedly elevated serum lactic acid.
  - name: N-terminal pro-brain natriuretic peptide (NT-proBNP)
    presence: Elevated
    context: Cardiac stress marker in Sengers syndrome with heart failure
    evidence:
      - reference: PMID:34164355
        supports: SUPPORT
        snippet: "N-terminal pro-brain natriuretic peptide (NT-proBNP) reached 6,076 pg/ml (reference ranges <125 pg/ml) reflecting the state of the heart failure."
        explanation: This provides biochemical evidence of elevated NT-proBNP in a Sengers syndrome patient with heart failure.
  - name: 3-hydroxybutyrate
    presence: Elevated
    context: Urinary organic acid analysis in Sengers syndrome
    biomarker_term:
      preferred_term: 3-hydroxybutyrate
      term:
        id: CHEBI:37054
        label: 3-hydroxybutyrate
    evidence:
      - reference: PMID:34164355
        supports: SUPPORT
        snippet: "Urinary organic acid analysis showed increased amounts of 3-hydroxybutyrate (25.5 mmol/L, normal <9.0 mmol/L)"
        explanation: This report documents elevated 3-hydroxybutyrate on urinary organic acid analysis.
treatments:
  - name: Coenzyme Q10 supplementation
    description: Coenzyme Q10 used as part of mitochondrial supportive therapy.
    evidence:
      - reference: PMID:34164355
        supports: SUPPORT
        snippet: "Supplementation with coenzyme Q10, carnitine, B-vitamins, and biotin (called mitochondrial cocktail) was given daily, associated with angiotensin converting enzyme (ACE) inhibitors for cardiomyopathy management."
        explanation: This case report lists coenzyme Q10 as part of a mitochondrial cocktail for Sengers syndrome.
      - reference: PMID:34164355
        supports: SUPPORT
        snippet: "Levocarnitine (100 mg/kg daily), coenzyme Q10 (1 mg/kg daily), and vitamin B complex (vitamin B1 20 mg/day and riboflavin 10 mg/day) were administered to improve metabolic status;"
        explanation: This provides dosing detail confirming coenzyme Q10 use in Sengers syndrome.
    treatment_term:
      preferred_term: coenzyme Q10 supplementation
      term:
        id: MAXO:0010012
        label: coenzyme Q10 supplementation
  - name: Carnitine supplementation
    description: L-carnitine provided as part of mitochondrial supportive therapy.
    evidence:
      - reference: PMID:34164355
        supports: SUPPORT
        snippet: "Supplementation with coenzyme Q10, carnitine, B-vitamins, and biotin (called mitochondrial cocktail) was given daily, associated with angiotensin converting enzyme (ACE) inhibitors for cardiomyopathy management."
        explanation: This case report lists carnitine within the mitochondrial cocktail for Sengers syndrome.
      - reference: PMID:34164355
        supports: SUPPORT
        snippet: "Levocarnitine (100 mg/kg daily), coenzyme Q10 (1 mg/kg daily), and vitamin B complex (vitamin B1 20 mg/day and riboflavin 10 mg/day) were administered to improve metabolic status;"
        explanation: This provides dosing detail confirming levocarnitine use in Sengers syndrome.
    treatment_term:
      preferred_term: carnitine supplementation
      term:
        id: MAXO:0010006
        label: carnitine supplementation
  - name: B vitamin supplementation
    description: Vitamin B complex supplementation as part of supportive therapy.
    evidence:
      - reference: PMID:34164355
        supports: SUPPORT
        snippet: "Supplementation with coenzyme Q10, carnitine, B-vitamins, and biotin (called mitochondrial cocktail) was given daily, associated with angiotensin converting enzyme (ACE) inhibitors for cardiomyopathy management."
        explanation: This case report lists B-vitamins within the mitochondrial cocktail for Sengers syndrome.
      - reference: PMID:34164355
        supports: SUPPORT
        snippet: "Levocarnitine (100 mg/kg daily), coenzyme Q10 (1 mg/kg daily), and vitamin B complex (vitamin B1 20 mg/day and riboflavin 10 mg/day) were administered to improve metabolic status;"
        explanation: This provides dosing detail confirming vitamin B complex use in Sengers syndrome.
    treatment_term:
      preferred_term: B vitamin supplementation
      term:
        id: MAXO:0000761
        label: B vitamin supplementation
  - name: ACE inhibitor therapy
    description: ACE inhibitor therapy used for heart failure management.
    evidence:
      - reference: PMID:34164355
        supports: SUPPORT
        snippet: "Supplementation with coenzyme Q10, carnitine, B-vitamins, and biotin (called mitochondrial cocktail) was given daily, associated with angiotensin converting enzyme (ACE) inhibitors for cardiomyopathy management."
        explanation: This case report notes ACE inhibitor use alongside mitochondrial cocktail therapy.
      - reference: PMID:34164355
        supports: SUPPORT
        snippet: "The patient received milrinone, diuretics (furosemide and spironolactone), and captopril to improve heart function."
        explanation: This provides direct evidence of ACE inhibitor (captopril) therapy in Sengers syndrome.
      - reference: PMID:38933059
        supports: SUPPORT
        snippet: "Baby was on regular follow-up and was thriving well on diuretics, sacubitril-valsartan and weekly levosimendan infusions."
        explanation: This neonatal case reports ongoing pharmacologic heart failure management including a neprilysin inhibitor/ARB regimen.
    treatment_term:
      preferred_term: ACE inhibitor therapy
      term:
        id: MAXO:0000652
        label: ACE inhibitor therapy
  - name: Cardiac transplantation
    description: Heart transplantation for severe cardiomyopathy in Sengers syndrome.
    evidence:
      - reference: PMID:8526648
        supports: SUPPORT
        snippet: "This report describes cardiac transplantation for the treatment of the cardiomyopathy associated with Sengers' syndrome."
        explanation: This case report documents cardiac transplantation as a treatment for Sengers-associated cardiomyopathy.
      - reference: PMID:38933059
        supports: SUPPORT
        snippet: "At 8 months of age, cardiac transplantation was successfully done and baby has been doing well post-transplantation."
        explanation: This neonatal case report describes successful cardiac transplantation in Sengers syndrome.
    treatment_term:
      preferred_term: cardiac transplantation
      term:
        id: MAXO:0010032
        label: cardiac transplantation
  - name: Diuretic therapy
    description: Diuretics used for heart failure management in Sengers syndrome.
    evidence:
      - reference: PMID:38933059
        supports: SUPPORT
        snippet: "Baby was on regular follow-up and was thriving well on diuretics, sacubitril-valsartan and weekly levosimendan infusions."
        explanation: This case report documents ongoing diuretic therapy as part of heart failure management.
      - reference: PMID:34164355
        supports: SUPPORT
        snippet: "The patient received milrinone, diuretics (furosemide and spironolactone), and captopril to improve heart function."
        explanation: This provides direct evidence of diuretic use in Sengers syndrome.
    treatment_term:
      preferred_term: diuretic agent therapy
      term:
        id: MAXO:0000165
        label: diuretic agent therapy
  - name: Levosimendan infusion
    description: Levosimendan infusions used for heart failure support.
    evidence:
      - reference: PMID:38933059
        supports: SUPPORT
        snippet: "Baby was on regular follow-up and was thriving well on diuretics, sacubitril-valsartan and weekly levosimendan infusions."
        explanation: This neonatal case report describes levosimendan infusions in Sengers syndrome.
datasets: []
differential_diagnoses:
  - name: Barth syndrome
    disease_term:
      preferred_term: Barth syndrome
      term:
        id: MONDO:0010543
        label: Barth syndrome
    description: >
      X-linked mitochondrial disorder with cardiomyopathy and metabolic features
      that can overlap with Sengers syndrome.
    distinguishing_features:
      - X-linked inheritance and neutropenia are typical for Barth syndrome.
      - Cardiolipin remodeling defects due to TAZ variants distinguish it from AGK-related Sengers syndrome.
    evidence:
      - reference: DOI:10.1007/s10545-014-9759-7
        supports: SUPPORT
        snippet: "Sengers syndrome (due to mutations in AGK), MEGDEL syndrome (or SERAC defect, SERAC1), Barth syndrome (or TAZ defect, TAZ)"
        explanation: This review lists Barth syndrome alongside Sengers syndrome among phospholipid metabolism disorders.
  - name: 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome
    disease_term:
      preferred_term: 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome
      term:
        id: MONDO:0013875
        label: 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome
    description: >
      SERAC1-related mitochondrial disorder (MEGDEL syndrome) with multisystem
      involvement and overlapping metabolic features.
    distinguishing_features:
      - Prominent deafness and Leigh-like neurodegeneration are typical.
      - SERAC1-related disease has a different genetic cause than AGK-related Sengers syndrome.
    evidence:
      - reference: DOI:10.1007/s10545-014-9759-7
        supports: SUPPORT
        snippet: "Sengers syndrome (due to mutations in AGK), MEGDEL syndrome (or SERAC defect, SERAC1), Barth syndrome (or TAZ defect, TAZ)"
        explanation: This review lists MEGDEL syndrome as a related phospholipid metabolism disorder to consider in the differential.
